All articles tagged: Migraine, unspecified (G43.9)
HealthDay
18 January at 11.08 PM
>30 Percent With Migraine Experience Migraine-Related Stigma OftenMore than 30 percent of individuals with migraine experience migraine-related stigma often or very often, according to a study published online Jan. 17 in Neurology.Robert E. Shapiro, M.D., Ph.D., from the Larner College of Medicine at the University of Vermont in Burlington, and colleagues examined the association between migraine-re |
|
HealthDay
17 January at 04.48 PM
Eye Blood Flow Could Be Marker for MigraineBlood flow appears to be reduced in the eye during migraine attacks, according to a study published online Nov. 30 in Headache: The Journal of Head and Face Pain.Katherine Podraza, M.D., Ph.D., from the University of California, Los Angeles, and colleagues used optical coherence tomography angiography (OCTA) to determine if ther |
|
HealthDay
22 December at 04.44 PM
Study Compares Effectiveness of Migraine Preventive DrugsFor patients with migraine, simvastatin, calcitonin gene-related peptide pathway antibodies (CGRPabs), and amitriptyline have a favorable effect compared with beta blockers, according to a study published in the January issue of the European Journal of Neurology.Marte H. Bjørk, M.D., Ph.D., from the University of Bergen in Norway, and c |
|
HealthDay
22 November at 04.53 PM
Ubrogepant Beneficial for Treating Migraine During the ProdromeUbrogepant is beneficial for the treatment of migraine when taken during the prodrome, according to a study published online Nov. 15 in The Lancet.David W. Dodick, M.D., from the Mayo Clinic in Phoenix, and colleagues examined the efficacy, safety, and tolerability of ubrogepant 100 mg versus placebo for acute treatment of migraine w |
|
HealthDay
13 November at 11.56 PM
FDA Approves First Treatment for Congenital Thrombotic Thrombocytopenic PurpuraThe U.S. Food and Drug Administration has approved Adzynma, the first recombinant protein product indicated for prophylactic or on-demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP).Adzynma is a purified recombinant form of the ADAMTS13 enzyme that enhances the low l |
Medical xPress
08 July at 06.16 AM
Scientists create first mouse model with complete, functional human immune systemA breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created a humanized mouse model with a human immune system and a human-like gut microbiome that is capable of mounting specific antibody responses. |
|
Medical xPress
05 July at 07.10 AM
When it comes to male life expectancy, nature and nurture work togetherAlthough the simple biological fact (nature) of being born male increases boys' and men's overall health risks, the behavioral choices (nurture) they make are at least as important. This means that trans men and others who identify as men, while not biologically male, may also experience the behavioral disadvantages of being male. |
|
Medical xPress
05 July at 06.50 AM
Study explores the link between stock market fluctuations and emergency room visits in ChinaThe advent of computerized trading and fintech platforms has made investing in stocks easier and more accessible to individuals worldwide. This has led to an increase in stock market participation in many countries, including China. |
|
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
|
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
|
|
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
|
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
|
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
|
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
